OBJECTIVES: Our aim was to evaluate outcomes following a total cavopulmonary connection (TCPC) in patients with preoperatively impaired ventricular function (VF).
INTRODUCTION
Generally, preoperatively impaired ventricular function (VF) is considered as a risk for a Fontan procedure. In 1978, Choussat et al. [1] suggested 10 selection criteria for a successful Fontan: (i) age > _ 4 years, (ii) normal VF, (iii) adequate pulmonary artery (PA) size, (iv) no distortion of PAs, (v) low PA pressure, (vi) low pulmonary vascular resistance, (vii) normal systemic venous drainage, (viii) no atrioventricular valve (AVV) regurgitation, (ix) normal sinus rhythm and (x) no right atrial enlargement. These '10 commandments' have been adapted over the years as basic criteria and play a major role in patient selection for a Fontan operation. However, since introduction of total cavopulmonary connection (TCPC) [2] , most of the criteria have been reconsidered because of developments in surgical techniques, improved postoperative care and an increased experience in hypoplastic left heart syndrome [3] . In the current era of a staged single ventricle palliation, a Fontan completion can be safely performed in patients aged 1-2 years [4, 5] . A distorted/stenotic PA, anomalous venous drainage and insufficient AVV can be repaired before the Fontan procedure. In 2007, Hosein et al. [6] examined the '10 commandments' in 406 Fontan patients and showed that only 2 of the 10 factors (preoperatively impaired VF and elevated PA pressures) had adverse effects on both early and late outcomes. Other studies have shown that an impaired VF is still a risk factor for morbidity and mortality [7, 8] . Some patients with severe ventricular dysfunction are potential candidates for heart transplantation [9, 10] .
However, Shiraishi et al. [11] reported that cardiac performance could improve following a TCPC in patients who had a reduced ventricular ejection fraction (EF) preoperatively. It was demonstrated that the aortopulmonary collateral flow is reduced following the TCPC [12] . They speculated that the increased oxygen supply and potential volume unloading of the systemic ventricle following a TCPC should have a protective effect on the systemic ventricle. Currently, with early-stage palliation including a bidirectional cavopulmonary shunt and TCPC, the impaired VF might improve following the TCPC. Now crucial issues include how far surgeons can extend the operative indication in this respect and how efficiently the Fontan circulation is maintained with a ventricle that has poor contractility preoperatively.
In this study, we reviewed our experience in patients who had an impaired VF before a TCPC, and its effect on postoperative outcomes and exercise capacity. Furthermore, we intended to identify the factors influencing preoperative VF and postoperative recovery.
MATERIALS AND METHODS
We reviewed the medical records of 483 consecutive patients who underwent a TCPC at the German Heart Center Munich between May 1994 and December 2016. The institutional review board of the Technical University of Munich approved the study. According to the previous studies by Kotani et al. [8] and Shiraishi et al. [11] and according to our clinical practice, impaired VF was defined as ventricular EF below 50%, n = 44 patients (Group A), and normal VF was defined as EF of 50% or more, n = 439 patients (Group B). The patient preoperative characteristics are listed in Table 1 .
Operative techniques and postoperative management
The operative techniques for a TCPC were described in our previous report [4] . In staged patients, antegrade pulmonary blood flow was eliminated at the time of bidirectional cavopulmonary shunt [13] . Fenestration was not routinely performed and was only used for high-risk patients [14] .
Follow-up data
The patients were followed up by paediatric cardiologists in an outpatient setting, and follow-up time was defined per patient as the time from operation to the last follow-up while censoring patients who died at the time of follow-up. The data were regularly tracked using our institutional Fontan patient database.
Echocardiography
An experienced echocardiographer reviewed the archived echocardiogram images from pre-and post-TCPC and assessed the systemic VF and AVV regurgitation. The M-mode assessment of systemic VF was performed, and the EF was calculated [15] . AVV regurgitation was graded as described in our previous study [14] .
Cardiopulmonary exercise capacity testing
A symptom-limited cardiopulmonary exercise test on a bicycle was performed as described in our previous study [14] .
Identification of factors affecting ventricular function and cardiac reoperation
To identify risk factors for VF and cardiac reoperation, we evaluated the variables related to the patient primary diagnosis, cardiac morphology, palliative surgeries and other conditions (Supplementary Material, Table S1 ).
Statistical analysis
Categorical variables are presented as absolute numbers and percentages. A v 2 test was used for categorical data. Continuous variables are expressed as means ± standard deviations or medians with interquartile ranges, if appropriate. An independent sample t-test was used to compare normally distributed variables. The Mann-Whitney test was used for variables that were not normally distributed. Levene's test was used to differentiate between normally and non-normally distributions. We used a multiple logistic regression method to establish the preoperative variables that were independently predictive of pre-TCPC impaired VF. Variables with a level of significance of <0.1 in a univariable analysis were assessed in multiple logistic regression models. Freedom from death or transplantation, cardiac reoperation, catheter intervention and protein losing enteropathy were determined using the KaplanMeier method, and differences between groups were determined using the log-rank test. Competing risk analysis was performed to parametrically model the probability over time to occurrence of 2 mutually exclusive end-points-reoperation and death before reoperation-the remainder of patients being alive and free from cardiac reoperation. Factors influencing cardiac reoperation were identified using the Cox regression method. Data analysis was performed using the Statistical Package for the Social Sciences (SPSS), version 22.0 for Windows (IBM, Ehningen, Germany).
RESULTS

Preoperative and operative data
Morphologically, the patients in Group A exhibited a higher incidence of single tricuspid valve (TV) (P < 0.001), heterotaxy (P = 0.009) and double-outlet right ventricle (P = 0.028), when compared with the patients in Group B (Supplementary Material, Table S2 ). Prior to the TCPC, the patients in Group A had more AVV operations (P = 0.005), systemic ventricular outflow tract (SVOT) interventions (P = 0.021), pacemaker implantation (P = 0.001) and cardiopulmonary resuscitation (P = 0.002), when compared with the patients in Group B (Supplementary Material, Table S3 ). Preoperative cardiac catheterization data (Supplementary Material, Table S4) indicated that the patients in Group A exhibited a higher left atrial pressure (P = 0.011).
The perioperative data are listed in Table 2 . The patients in Group A had a longer cardiopulmonary bypass time (P = 0.015). The percentage of patients requiring aortic cross-clamping (P = 0.009) was significantly higher, and concomitant procedures including Damus-Kaye-Stansel anastomosis (P = 0.003) and an AVV procedure (P < 0.001) were performed more frequently in Group A.
Postoperative recovery and mortality
The 30-day mortality was 2.3% (1 patient) in Group A and 1.6% (7 patients) in Group B (P = 0.737). The causes of death are listed in Supplementary Material, Table S5 . For Groups A and B, the median intensive care unit stay (7.0 vs 7.0, respectively; P = 0.423) and median hospital stay (19.5 vs 21.0, respectively; P = 0.932) were not significantly different between groups (Table 2) .
Follow-up outcomes
Of the 475 early survivors, 10 (2.1%) patients were lost to followup after hospital discharge. The median follow-up period was 6.2 (1.5-11.6) years for the remaining 465 patients. Fifteen patients experienced a late death (4 patients in Group A and 11 in Group B). One patient in Group B required heart transplantation 5 months after TCPC. According to the Kaplan-Meier method, the estimated overall survival had no significant differences between the 2 groups with 10-year point estimates of 86.8% in Group A and 94.1% in Group B (P = 0.115; Supplementary Material, Fig. S1 ). A cardiac reoperation was necessary for 12 (27.3%) patients in Group A (6 AVV procedures, 3 aortic valve procedures, 1 aortic arch reconstruction and 2 secondary fenestration procedures) and for 28 (8.4%) patients in Group B (7 AVV procedures, 3 ascending aorta/aortic arch procedures, 7 revision of the TCPC tunnel, 1 aortic valve procedure, 1 resection of a subaortic stenosis, 1 PA procedure and 8 secondary fenestration procedures). The estimated freedom from cardiac reoperation was significantly different between the 2 groups with a 10-year point estimate of 66.1% in Group A and 91.6% in Group B (P < 0.001; Supplementary Material, Fig. S2 ). Competing risks analysis of death and cardiac reoperation indicated that 28.7% of the patients had undergone a cardiac reoperation, 13.1% had died and 58.1% were alive without reoperation at 10 years after TCPC in Group A (Fig. 1) , whereas in Group B, 7.3% of the patients had undergone a cardiac reoperation, 5.9% had died and 86.7% were alive without reoperation at 10 years after TCPC (Fig. 2) . The Cox regression analysis for cardiac reoperation revealed that preoperative impaired VF (P = 0.003) and dominant right ventricle (P = 0.031) were independent risk factors (Table 3) . Preoperative impaired VF (P < 0.001) had a stronger statistical value than preoperative EF (P = 0.015).
A catheter intervention was required for 8 (18.2%) patients in Group A and for 80 (18.2%) patients in Group B: freedom from a catheter intervention had no significant differences between the 2 groups with 10-year point estimates of 80.2% in Group A and 76.1% in Group B (P = 0.603). Protein losing enteropathy developed in 2 (4.5%) patients in Group A and in 14 (3.2%) patients in Group B: freedom from protein losing enteropathy was not significantly different between the 2 groups with 10-year point estimates of 94.5% in Group A and 94.7% in Group B (P = 0.931).
Cardiopulmonary exercise test
Data on cardiopulmonary exercise testing were available from 23 patients in Group A at a mean time of 10.7 ± 4.1 years following TCPC and from 124 patients in Group B at a mean time of 11.1 ± 4.6 years following TCPC, P = 0.703. There was no significant difference in the mean peak VO 2 (26.5 ± 7.5 vs 29.4 ± 8.5 ml/ kg/min, respectively; P = 0.135) or in the age-and sex-related corrected peak VO 2 (66.6 ± 15.5 vs 71.2 ± 18.2%, respectively; P = 0.260) between the groups.
Change in systemic ventricular and atrioventricular valve function
Systemic VF, as well the degree of AVV regurgitation, was studied from the last available echocardiographic report [n = 449, median postoperative time of 6.5 (1.5-11.9) years]. Data were available for 39 patients in Group A and from 410 patients in Group B. As for the 39 Group A survivors, VF was resolved in 22 (56.4%) patients at the median 1.4 (0.9-2.1) years postoperatively ( Fig. 3) and had normal VF (EF 56.6 ± 2.3%). The remaining 17 patients still had reduced VF (EF 42.2 ± 4.1%). Mild or moderate AVV Table S6 ), AVV reoperation (P = 0.002) and pacemaker-dependent rhythm (P = 0.006) following TCPC were only observed in patients without recovered VF. Patients of Group A were assigned to subgroups of patients with and without AVV surgery (Supplementary Material, Table  S7 ). Twenty-four patients required AVV surgery before (n = 12) and/or at (n = 14) the TCPC, and they exhibited higher incidence of single TV (P = 0.042).
Era analysis was performed to investigate the data in 2 periods: early era (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) , 167 patients) and latter era (2005-2016, 316 patients). Although survival and reoperation were better in the latter era, the statistical results of the latter era were similar to those of all patients.
DISCUSSION
This study reports comparable early and mid-term outcomes except for cardiac reoperation in patients undergoing TCPC with impaired VF when compared with patients with normal VF. VF was resolved in 22 (56%) patients during follow-up.
Causes of impaired ventricular function
Our results show that impaired VF is frequently associated with AVV regurgitation. Twenty-four of the 44 (55%) patients with impaired VF had significant AVV regurgitation requiring AVV surgery before and/or at the TCPC. Many studies have reported that impaired VF and AVV regurgitation are closely related [16, 17] . In this context, ventricular dysfunction may be either the cause or the result of AVV regurgitation. Honjo et al. [16] reported that impaired VF and ventricular dilatation at the time of AVV repair were correlated with worse outcomes. For hypoplastic left heart syndrome patients, Ohye et al. [17] reported that early tricuspid repair in the presence of preserved right VF yielded good longterm results. However, if repair was performed in the presence of impaired VF, progressive post-repair ventricular dysfunction could cause redilatation of the AVV annulus [17] . In this study, ventricular dysfunction at TCPC did not increase long-term mortality presumably because we observed recovery of VF following AVV surgery on TCPC. Chronic volume overload-related ventricular dysfunction due to AVV regurgitation might be reversible after successful AVV surgery. Hence, in this study, impaired VF prior to TCPC might rather have been the sequelae of AVV regurgitation than of intrinsic ventricular dysfunction. Furthermore, impaired VF following TCPC might be also the sequelae of AVV pathologies, because all 6 patients who needed repeat AVV surgery had structural valve abnormalities and did not recover their VF.
It is of note that 18 of the 24 patients, who exhibited impaired VF and AVV regurgitation, presented with a single TV. It is well known that the TV in systemic position is prone to fail, with the potential consequence of ventricular dysfunction. Therefore, in our experience, AVV regurgitation as the most important cause of prior to Fontan impaired VF, occurred mainly in patients with TV failure and dominant RV.
In this study, heterotaxy was a risk for ventricular dysfunction. Patients with heterotaxy and a functional single ventricle frequently present with a common AVV that will ultimately fail and cause ventricular dysfunction [18] . Therefore, surgical management of patients with heterotaxy and a functional single ventricle still remains challenging, not at least because of multiple associated cardiovascular defects; although recent studies reported improved outcomes [19] . Our study identified pacemaker implantation to be associated with impaired VF at the time of TCPC. Dual chamber pacemakers were implanted exclusively, and atrioventricular sequential pacing was applied. However, these patients had a tendency not to recover their impaired VF following TCPC. Currently, data are not available on optimal lead positioning on the single ventricle. Apparently, sinus rhythm seems to be important for preserving VF in patients with a single ventricle.
SVOT obstruction has been reported as a cause of ventricular dysfunction [20] . Pressure overload of systemic ventricle induces ventricular hypertrophy, ventricular dilatation and finally ventricular dysfunction. In our study, SVOT obstruction requiring intervention was significantly more frequent in patients presenting with impaired VF.
Impact of a Fontan completion on impaired ventricular function
In this study, all patients but one with impaired VF tolerated the TCPC. Early postoperative recovery in patients with impaired VF was comparable with those with normal VF. Overall survival and exercise capacity at the 10-year follow-up were not significantly different between patients with and without impaired VF. Thus, contemporary TCPC might have protective effects on ventricular contractility presumably due to increased oxygen delivery to the myocardium. Potential volume unloading of the systemic ventricle following TCPC, due to the decrease of aortopulmonary collateral flow, may add a second positive effect. Shiraishi et al.
[11] examined 52 patients who underwent TCPC with a preoperative EF of 50% or lower. Accordingly, they observed a reduction in ventricular volume and an increase in the EF [11] . Tanoue et al. [21] reported that the volume load reduction on the systemic ventricle resulted in improved contractility after the TCPC. Kotani et al. [8] examined 29 patients who had an impaired VF and observed improved EF (43-59%) and elevated percutaneous oxygen saturation (82-92%) following TCPC. In our study, 22 of the 39 survivors (56%) with a reduced VF exhibited recovery of VF following TCPC, and their oxygen saturation increased from 82% to 94%. Our study findings and other reports strongly suggest a benefit from TCPC even in patients with preoperative impaired VF.
Management strategy for impaired ventricular function prior to a Fontan completion
According to our results, several prerequisites are essential to preserve systemic VF prior to TCPC. Figure 4 presents a flow chart of the current management in a single-ventricle patients with AVV regurgitation and ventricular dysfunction. As older age at TCPC was significantly more frequent in patients with impaired VF, early volume unloading by bidirectional cavopulmonary shunt followed by early Fontan completion seems to be essential to preserve VF. Extracardiac TCPC might shorten the cardiopulmonary bypass time and avoid myocardial ischemia in patients who do not need concomitant intracardiac procedures. We recently prefer to perform AVV procedure as a sole therapy rather than concomitant with TCPC [22] . Our results indicate that fenestration is not necessary to perform an extracardiac TCPC in patients with impaired VF.
In our study, more than half of the patients with impaired VF had associated AVV regurgitation. Furthermore, VF did not resolve in all 6 patients who needed repeat AVV surgery. Therefore, prompt and successful management of AVV regurgitation even in the inter-stage period is mandatory to maintain adequate VF.
Early diagnosis and relief of SVOT obstruction is another important issue to preserve VF. In patients with potential risk for subaortic stenosis, such as double-inlet left ventricle with 
Limitations
This study was limited by its retrospective and single-centre design. Data were not available at consistent follow-up periods for every patient. Qualitative assessment and grading are not the most accurate methods for evaluating VF. Changes over time in surgical and medical management might have affected the longterm outcomes. Another limitation of the study is that not all patients had a recent cardiopulmonary exercise test. The finite number of cardiopulmonary exercise tests might have limited the reliability of the results.
CONCLUSIONS
A Fontan completion with a TCPC in patients with impaired VF can be performed with low perioperative risk, and patients can have comparable intermediate results except for cardiac reoperation with those with normal VF. Postoperative improvement of VF was observed in >50% of the patients, and a competent AVV and sinus rhythm are prerequisites for recovery.
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